Loading clinical trials...
Loading clinical trials...
Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutations in Patients With Advanced or Metastatic NSCLC at Front-line and Progression
Conditions
Locations
10
Argentina
Research Site
CABA, Argentina
Research Site
Córdoba, Argentina
Research Site
La Plata, Argentina
Research Site
Rosario, Argentina
Research Site
Santiago, Chile
Research Site
Bogotá, Colombia
Start Date
November 29, 2018
Primary Completion Date
March 9, 2019
Completion Date
March 9, 2019
Last Updated
June 12, 2019
NCT06667908
NCT04165798
NCT06875310
NCT07046923
NCT07222566
NCT06667076
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions